230
Participants
Start Date
April 17, 2014
Primary Completion Date
April 20, 2019
Study Completion Date
June 18, 2019
Deferiprone
Deferoxamine
Thomas Jefferson University, Philadelphia
Medical University of South Carolina, Charleston
University of Michigan Comprehensive Cancer Center, Ann Arbor
Children's Hospital of Michigan, Detroit
University of Illinois at Chicago, Chicago
Children's Hospital, New Orleans
King Abdulaziz University Hospital, Jeddah
Children's Hospital Oakland, Oakland
The Children's Hospital of Philadephia, Philadelphia
Centro Infantil Boldrini, Campinas
Casa de Saúde Santa Marcelina, São Paulo
Universidade Federal de São Paulo, São Paulo
Hospital for Sick Kids, Toronto
Mansoura University Children's Hospital, Al Mansurah
Alexandria University, Alexandria
Zagazig University, Alexandria
Ains Shams University, Cairo
Cairo University, Cairo
Pediatric Hospital of Cairo University, Cairo
Asser Central Hospital, Abhā
King Khalid University Hospital, Riyadh
National Center for Bone Marrow Transplantation, Tunis
Farhat Hached Hospital, Hematology Department, Sousse
Principal Military Hospital of Instruction of Tunis, Tunis
Cukurova University, Adana
Hacettepe University, Ankara
Istanbul University, Istanbul
Barts and The London, London
Evelina Children's Hospital, London
Imperial College Healthcare NHS Trust, London
Hospital de Clínicas de Porto Alegre-HCPA,, Rio Branco
Instituto Estadual de Hematologia Arthur Siqueira Cavalcanti - HEMORIO, Rio de Janeiro
Hammersmith Hospital, London
Lead Sponsor
ApoPharma
INDUSTRY